Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3- phosphocholine

Lipids

Volumn 32, Issue 7, 1997, Pages 715-723

  Small, George W ^a,b   Strum, Jay C ^a,c   Daniel, Larry W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHLOROQUINE; EDELFOSINE; ETHER LIPID; FLUORIDE SODIUM; LIPOPROTEIN; MONENSIN; POTASSIUM CYANIDE; SERUM ALBUMIN;

ARTICLE; CELL GROWTH; CELL STRAIN HL 60; CONTROLLED STUDY; DNA SYNTHESIS; DRUG RECEPTOR BINDING; DRUG RESISTANCE; DRUG SENSITIVITY; ENDOCYTOSIS; HUMAN; HUMAN CELL; INTERNALIZATION;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CULTURE MEDIA, SERUM-FREE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; PHOSPHOLIPID ETHERS; PHOSPHOLIPIDS; SERUM ALBUMIN, BOVINE; VARIATION (GENETICS);

EID: 0030816631     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-997-0091-3     Document Type: Article

References (50)

1. Kudo, I., Nojima, S., Chang, H.W., Yanoshita, R., Hayashi, H., Kondo, E., Nomura, H., and Inoue, K. (1987) Antitumor Activity of Synthetic Alkyl-Phospholipids With or Without PAF Activity, Lipids 22, 862-867.
2. 3H-paf-Acether Binding to Platelets from Humans in vitro. Anticancer Res. 7, 1181-1187.
3. Berdel, W.E. (1991) Membrane-Interactive Lipids as Experimental Anticancer Drugs, Br. J. Cancer 64, 208-211.
4. Andreesen, R. (1988) Ether Lipids in the Therapy of Cancer, Prog. Biochem. Pharmacol. 22, 118-131.
5. Daniel, L.W. (1991) Ether Lipids in Experimental Cancer Chemotherapy, in Cancer Chemotherapy (Hickman, J.A., and T.R. Tritton, eds.) pp. 146-178, Blackwell Scientific Publications, Ltd., Oxford.
6. 2+ Signaling by Antitumor Ether Lipid Analogues, Cancer Res. 50, 4458-4463.
7. Powis, G., Seewald, M.J., Gratas, C., Melder, D., Riebow, J., and Modest, E.J. (1992) Selective Inhibition of Phosphatidyl-inositol Phospholipase C by Cytotoxic Ether Lipid Analogues, Cancer Res. 52, 2835-2840.
8. 2+-Dependent Protein Phosphorylation System in Various Types of Leukemic Cells from Human Patients and in Human Leukemic Cell Lines HL60 and K562, and Its Inhibition by Alkyllysophospholipid, Cancer Res. 43, 2955-2961.
9. Modolell, M., Andreesen, R., Pahlke, W., Brugger, W., and Munder, P.G. (1979) Disturbance of Phospholipid Metabolism During the Selective Destruction of Tumor Cells Induced by Alkyl-lysophospholipids, Cancer Res. 39, 4681-4686.
10. Herrmann, D.B.J. (1985) Changes in Cellular Lipid Synthesis of Normal and Neoplastic Cells During Cytolysis Induced by Alkyl Lysophospholipid Analogues, J. Natl. Cancer Inst. 75, 423-430.
11. Chabot, M.C., Wykle, R.L., Modest, E.J., and Daniel, L.W. (1989) Correlation of Ether Lipid Content of Human Leukemia Cell Lines and Their Susceptibility to 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine, Cancer Res. 49, 4441-4445.
12. Kuo, J.F., Shoji, M., Kiss, Z., Girard, P.R., Deli, K., Oishi, K., and Vogler, W.R. (1988) Protein Kinase C in Cell Growth and Differentiation, Life Sci. 14, 9-20.
13. Marasco, C.J., Piantadosi, C., Meyer, K.L., Morris-Natschke, S., Ishaq, K.S., Small, G.W., and Daniel, L.W. (1987) Synthesis and Biological Activity of Novel Quaternary Ammonium Derivatives of Alkylglycerols as Potent Inhibitors of Protein Kinase C, J. Med. Chem. 33, 985-992.
14. Marx, M.H., Piantadosi, C., Noseda, A., Daniel, L.W., and Modest, E.J. (1988) Synthesis and Evaluation of Neoplastic Cell Growth Inhibition of 1-N-Alkylamide Analogues of Glycero-3-phosphocholine, J. Med. Chem. 31, 858-863.
15. Parker, J., Daniel, L.W., and Waite, M. (1987) Evidence of Protein Kinase C Involvement in Phorbol Diester-Stimulated Arachidonic Acid Release and Prostaglandin Synthesis, J. Biol. Chem. 262, 5385-5393.
16. 3 Inhibits Nuclear Factor-KB Activation by 12-O-Tetradecanoylphorbol-13-acetate But Not by Tumor Necrosis Factor-α or Interleukin 1α, Cancer Res. 55, 4844-4849.
17. Daniel, L.W., Etkin, L.A., Morrison, B.T., Parker, J., Morris-Natschke, S., Surles, J.R., and Piantadosi, C. (1987) Ether Lipids Inhibit the Effects of Phorbol Diester Tumor Promoters, Lipids 22, 851-855.
18. Boggs, K.P., Rock, C.O., and Jackowski, S. (1995) Lysophosphatidylcholine Attenuates the Cytotoxic Effects of the Antineoplastic Phospholipid 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine, J. Biol. Chem. 270, 11612-11618.
19. van Blitterswijk, W.J., van der Bend, R.L., Kramer, U.M., Verhoeven, A.J., Hilkmann, H., and de Widt, J. (1987) A Metabolite of an Antineoplastic Ether Phospholipid May Inhibit Transmembrane Signalling via Protein Kinase C, Lipids 22, 842-846.
20. Hoffman, D.R., Hoffman, L.H., and Snyder, F. (1987) Cytotoxicity and Metabolism of Alkyl Phospholipid Analogues in Neoplastic Cells, Cancer Res. 46, 5803-5809.
21. Wilcox, R.W., Wykle, R.L., Schmitt, J.D., and Daniel, L.W. (1987) The Degradation of Platelet Activating Factor and Related Lipids: Susceptibility to Phospholipases C and D, Lipids 22, 800-807.
22. Diomede, L., Monzani, E., Tacconi, M.T., and Salmona, M. (1992) Synthetic Ether Lipids Fluidizing Action and Cell Membrane Lipid Composition: A Commentary Note, Intl. J. Cancer 52, 162-163.
23. Andreesen, R., Modolell, M., and Munder, P.G. (1979) Selective Sensitivity of Chronic Myelogenous Leukemia Cell Populations to Alkyl-lysophospholipids, Blood 54, 519-523.
24. Bazill, G.W., and Dexter, T.M. (1990) Role of Endocytosis in the Action of Ether Lipids on WEHI-3B, HL60, and FDCP-Mix A4 cells, Cancer Res. 50, 7505-7512.
25. Fleer, E.A.M., Berkovic, D., Eibl, H., and Unger, C. (1993) Investigations on the Cellular Uptake of Hexadecylphosphocholine, Lipids 28, 731-736.
26. Storch, J., and Munder, P.G. (1987) Increased Membrane Permeability for an Antitumoral Alkyl Lysophospholipid in Sensitive Tumor Cells, Lipids 22, 813-819.
27. Kelley, E.E., Modest, E.J., and Burns, C.P. (1987) Unidirectional Membrane Uptake of the Ether Lipid Antineoplastic Agent Edelfosine by L1210 Cells, Biochem. Pharmacol. 45, 2435-2439.
28. Tidwell, T., Guzman, G., and Vogler, W.R. (1987) The Effects of Alkyl-lysophospholipids on Leukemic Cell Lines, HL60 and K562, Blood 57, 794-797.
29. Hoffman, D.R., Hajdu, J., and Snyder, F. (1984) Cytotoxicity of Platelet Activating Factor and Related Alkyl-phospholipid Analogs in Human Leukemia Cells, Polymorphonuclear Neutrophils, and Skin Fibroblasts, Blood 63, 545-552.
30. Yui, S., and Yamazaki, M. (1986) Induction of Macrophage Growth by Lipids, J. Immunol. 136, 1334-1338.
31. Daniel, L.W., Waite, M., and Wykle, R.L. (1986) A Novel Mechanism of Diglyceride Formation, J. Biol. Chem. 261, 9128-9132.
32. Rouser, G., Siakotos, A.N., and Fleischer, S. (1966) Quantitative Analysis of Phospholipids by Thin-layer Chromatography and Phosphorus Analysis of Spots, Lipids 1, 85-86.
33. Rudel, L.L., and Morris, M.D. (1973) Determination of Cholesterol Using o-Phthalaldehyde, J. Lipid Res. 14, 364-367.
34. Sleight, R.G., and Abanto, M.N. (1989) Differences in Intracellular Transport of a Fluorescent Phosphatidyl Choline Analog in Established Cell Lines, J. Cell Sci. 939, 363-374.
35. Mohandas, N., Wyatt, J., Mel, S.F., Rossi, M.E., and Shohet, S.B. (1982) Lipid Translocation Across the Human Erythrocyte Membrane, J. Biol. Chem. 257, 6537-6543.
36. Schumaker, V.N., and Puppione, D.L. (1986) Sequential Flotation Ultracentrifugation, Methods Enzymol. 128, 155-170.
37. Scharschmidt, G.F., Lake, J.F., Renner, E.L., Licko, V., and van Dyke, R.W. (1986) Fluid Phase Endocytosis by Cultured Rat Hepatocytes and Perfused Rat Brain: Implications for Plasma Membrane Turnover and Vesicular Trafficking of Fluid Phase Markers, Proc. Natl. Acad. Sci. USA 83, 9488-9492.
38. Kötting, J., Marschner, N.W., Neumuhller, W., Unger, C., and Eibl, H. (1992) Hexadecylphosphocholine and Octadecymethyl-glycero-3-phosphocholine: A Comparison of Hemolytic Activity, Serum Binding and Tissue Distribution. Alkylphosphocholines: New Drugs in Cancer Therapy, Prog. Exp. Tumor Res. 34, 131-142.
39. Dean, R.T., Jessup, W., and Roberts, C.R. (1984) Effects of Exogenous Amines on Mammalian Cells with Particular Reference to Membrane Flow, Biochem. J. 217, 27-40.
40. De Duve, G., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., and Van Hoof, F. (1974) Lysosomotropic Agents, Biochem. Pharmacol. 23, 2495-2531.
41. Mollenhauer, H.H., Morre, D.J., and Rowe, L.D. (1990) Alteration of Intracellular Traffic by Monensin: Mechanism, Specificity and Relationship to Toxicity, Biochim. Biophys. Acta 1031, 225-246.
42. Steinman, R.M., and Cohn, Z.A. (1972) The Interaction of Soluble Horseradish Peroxidase with Mouse Peritoneal Macrophages in vitro, J. Cell Biol. 55, 186-204.
43. Van Den Besselaar, A.M.H.P., Van Den Bosch, H., and Van Deenen, L.L.M. (1977) Biochim. Biophys. Acta 465, 454-465.
44. Gottlieb, T.A., Ivanov, I.E., Adesnik, M., and Sabatini, D.D. (1993) Actin Microfilaments Play a Critical Role in Endocytosis at the Apical But Not the Basolateral Surface of Polarized Epithelial Cells, J. Cell Biol. 120, 695-710.
45. Steinman, R.M., Mellman, I.S., Muller, W.A., and Cohn, Z.A. (1983) Endocytosis and the Recycling of Plasma Membrane, J. Cell Biol. 96, 1-27.
46. Sandvig, K., and van Deurs, B. (1990) Selective Modulation of the Endocytic Uptake of Ricin and Fluid Phase Markers Without Alteration in Transferrin Endocytosis, J. Biol. Chem. 265, 6382-6388.
47. Boscoboinik, D., and Epand, R.M. (1989) Increased Cellular Internalization of Amphiphiles in a Multidrug-Resistant CHO Cell Line, Biochim. Biophys. Acta 1014, 53-56.
48. Himmelmann, A.W., Danhauser-Riedl, S., and Steinhauser, G. (1990) Cross-Resistance Pattern of Cell Lines Selected for Resistance Towards Different Cytotoxic Drugs to Membrane-Toxic Phospholipids in vitro, Cancer Chemother. Pharmacol. 26, 437-446.
49. Glasser, L., Somberg, L. B., and Vogler, W. R. (1984) Purging Murine Leukemic Marrow With Alkyl-Lysophospholipids, Blood 64, 1288-1291.
50. Vogler, W.R., Berdel, W.E., and Olson, A.C. (1990) Ether Lipids as Purging Agents for Autologous Bone Marrow Transplantation, Cancer Res. Clin. Oncol. 116, 994.